Delivery Order SPE2DB20D2014-SPE2DB24FC53H

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The fixed-price contract has a ceiling value of $5,606.52 and an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Aimovig 140 mg/mL autoinjector. The contract has a ceiling value of $6,677.44 and a period of performance through September 30, 2024. It is a firm-fixed-price contract type. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation. This delivery order is likely part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $31,305.20 and is a firm fixed price, non-set-aside delivery order with a period of performance through May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $19,408.15 and is a firm-fixed-price delivery order that will be completed by October 16, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, is the prime contractor. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Aimovig 140 mg/mL autoinjector medication. The contract has a total ceiling value of $6,789.30 and a period of performance through July 31, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This award is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of a specific pharmaceutical product, Aimovig 140 mg/ml autoinjector, with a ceiling value of $1,264.14 and a completion date of February 27, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. As a key...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of the pharmaceutical product Aimovig 70 mg/ml autoinjector. The contract has a ceiling value of $5,606.51 and a completion date of May 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, with a ceiling value of $2,388.40 and a completion date of June 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription pharmaceutical Aimovig 70 mg/mL autoinjectors. The contract has an ultimate completion date of June 13, 2024 and a ceiling value of $2,984.70. AmerisourceBergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is leveraging its extensive supply chain network to fulfill this order. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Aimovig 140 mg/ml autoinjectors. The $1,810.48 firm-fixed-price contract has a period of performance through November 4, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC53H
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Aimovig 140 mg/ml autoinjector. The fixed-price contract has a ceiling value of $3,168.34 and a period of performance through July 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This order does not have a set-aside designation.

Generated 10/18/24, 9:11 AM